002210Dong Sung Bio Pharm.002210 info
$3.37info0.56%24h
Global rank22645
Market cap$77.13M
Change 7d0.22%
YTD Performance-21.53%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Dong Sung Bio Pharm. (002210) Stock Overview

    Dong Sung Bio Pharm.Co.,Ltd. manufactures and sells pharmaceuticals and cosmetics in South Korea. The company offers over the counter drugs, such as emollient, vitamin supplement, alopecia treatment, antihistamines, liver disease treatment, fire extinguisher solvent, antiviral, eye drops, menopause treatment, sleep inducer, antipyretic, analgesic, anti-inflammatory, vascular reinforcement, broad-spectrum skin disease treatment, gum disease treatment, blood circulation improver, scar treatment, dry stomach, eye nourishment, abdominal obesity treatment, anti-soil agent, respiratory solvent, and antifungal agent. It also provides prescription drugs, including endocrine system, corticosteroids, fire extinguishing system, circulatory system, psychotropic solvents, tumor therapy, analgesic anti-inflammatory, cutaneous urinary system, antiviral, antibiotics, and respiratory system. In addition, the company offers hair dye, cosmetics, health functional supplements, nasal spray, household goods, muscle taping, disinfectant, toothpaste, anti-hair loss shampoo, and sanitary napkin. The company was founded in 1957 and is headquartered in Seoul, South Korea.

    002210 Stock Information

    Symbol
    002210
    Address
    Dongsung BuildingSeoul, 01340South Korea
    Founded
    -
    Trading hours
    -
    Website
    https://dongsung-pharm.com
    Country
    🇰🇷 South Korea
    Phone Number
    82 2 6911 3600

    Dong Sung Bio Pharm. (002210) Price Chart

    -
    Value:-

    Dong Sung Bio Pharm. Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $3.37
    N/A
    Market Cap
    $77.13M
    N/A
    Shares Outstanding
    22.87M
    N/A
    Employees
    298.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org